CClinicalTrials.gg
Status unknownNCT02445274Updated May 3, 2016

Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification

An interventional study of Anterior lens capsule was reserved in Cataract and Posterior Capsule Opacification, sponsored by Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-05-03.

Sponsored by Sun Yat-sen University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
50 Years to 90 Years
Sex
All
01

Study summary

In this study, the investigators introduce a new "capsule-reserved" cataract surgical procedure in which anterior lens capsule is reserved and attached onto posterior lens capsule in the purpose of preventing posterior capsule opacification (PCO). A prospective randomized controlled study is reported to compare the new "capsule-reserved" surgical procedure with conventional one on the effectiveness to prevent posterior capsule opacification in age-related cataract patients.

Read the detailed description

A prospective, randomized controlled study of 240 eligible patients will been enrolled. Two eyes of each patient were assigned randomly to two groups respectively: Group I; anterior lens capsule is conventionally not reserved after continuous curvilinear capsulorhexis, while in Group II, anterior lens capsule is innovatively reserved and attached onto posterior lens capsule. This novel adjusted surgical procedure, featured by using the reserved anterior lens capsule to protect the peri-capsule microenvironment and prevent PCO, is conceptual different from the traditional cataract surgical procedure. Clinical examinations including posterior capsule opacification grading score, central posterior capsule thickness, central posterior capsule density, best corrected visual acuity, contrast sensitivity were carried out preoperatively and at each postoperative visit.

02

Conditions studied

  • Cataract
  • Posterior Capsule Opacification
03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 240 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Aged 50 years or above
  2. Both eyes were diagnosed with age-related cataract
  3. Both eyes were planed to undergo the "Phacoemulsification and IOL implantation" surgery with 1 month
  4. Biocular BCVA improvement post surgery was feasible judged by the ophthalmologists.

Exclusion criteria

Exclusion Criteria:

  1. Other ocular diseases
  2. ACD\<3CT
  3. Combined cataract surgery (trabeculoplasty, keratoplasty)
  4. Lens pseudoexfoliation syndrome combined with glaucoma or zonular abnormalities
  5. Previous intraocular surgery or trauma (laser not included)
  6. Uveitis
  7. Recent ocular infection
  8. Proliferative diabetic retinopathy
  9. Diabetes mellitus
  10. Congenital ocular abnormalities (aniridia, congenital cataract)
  11. Atrophy of iris
  12. Participants with previous clinical trials 30 days before surgery
  13. Using prostanoid eye drops
  14. Uncontrolled systematic diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Capsule-reserved surgical procedure

    In this group, the anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule. Phacoemulsification was performed with the same device and handpieces, using the same phaco chop technique as in the conventional procedure group.

    Procedure: Anterior lens capsule was reserved

  • No intervention
    Conventional surgical procedure

    In this group, the anterior lens capsule was not reserved or attached onto the posterior lens capsule.

Interventions

  • ProcedureAnterior lens capsule was reserved

    The anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in posterior capsule opacification grading score

    Posterior capsule opacification(PCO)was recorded by standardized slit lamp retroillumination images and analyzed using the EPCO2000 program. The severity of PCO was clinically graded from 0 (none) to 4 (severe)

    Time frame: post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3,

Secondary outcomes

  1. Change from Baseline in central posterior capsule thickness

    Central posterior capsule thickness was recorded and calculated by Pentacam HR system

    Time frame: post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

  2. Change from Baseline in central posterior capsule density

    Central posterior capsule density was recorded and calculated by Pentacam HR system.

    Time frame: post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

Other outcomes

  1. Change from Baseline in best corrected visual acuity

    Best-corrected visual acuity (BCVA) was measured, using an ETDRS chart and auto-refraction as refined by an ophthalmologist.

    Time frame: post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

  2. Change from Baseline in contrast sensitivity

    Contrast sensitivity under mesopic and photopic conditions was measured using C-quant

    Time frame: post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

07

Study locations

1 of 1 sites recruiting
  • Zhognshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong 510060, China
    Recruiting
08

References and documents

Publications

  • Luo L, Lin H, Chen W, Qu B, Zhang X, Lin Z, Chen J, Liu Y. Intraocular lens-shell technique: adjustment of the surgical procedure leads to greater safety when treating dense nuclear cataracts. PLoS One. 2014 Nov 17;9(11):e112663. doi: 10.1371/journal.pone.0112663. eCollection 2014. PubMed 25401512 ↗
  • Lin H, Yan P, Yu K, Luo L, Chen J, Lin Z, Chen W. Anterior segment variations after posterior chamber phakic intraocular lens implantation in myopic eyes. J Cataract Refract Surg. 2013 May;39(5):730-8. doi: 10.1016/j.jcrs.2012.12.026. Epub 2013 Mar 14. PubMed 23499067 ↗
  • Lin HT, Chen WR, Ding ZF, Chen W, Wu CR. Clinical evaluation of two multifocal intraocular lens implantation patterns. Int J Ophthalmol. 2012;5(1):76-83. doi: 10.3980/j.issn.2222-3959.2012.01.16. Epub 2012 Feb 18. PubMed 22553760 ↗
  • Luo L, Lin H, He M, Congdon N, Yang Y, Liu Y. Clinical evaluation of three incision size-dependent phacoemulsification systems. Am J Ophthalmol. 2012 May;153(5):831-839.e2. doi: 10.1016/j.ajo.2011.10.034. Epub 2012 Feb 4. PubMed 22310081 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02445274
Lead sponsor
Sun Yat-sen University
Responsible party
Haotian Lin (Associate Professor, Sun Yat-sen University) — Principal investigator
First posted
May 15, 2015
Start date
May 2015
Primary completion
Aug 2016 (estimated)
Completion
Aug 2016 (estimated)
Last update
May 3, 2016

Study contacts

Haotian Lin, M.D., PhD
Contact
haot.lin@hotmail.com
8613802793086
Xiaohang Wu, M.D.
Contact
1034281949@qq.com
+86-20-87330341
Yizhi Liu, M.D., PhD
principal investigator · Zhongshan Ophthalmic Center, Sun Yat-sen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion